Konidaris Tasos sold AMRX
March 4, 2026 · Form 4 insider transaction
Konidaris Tasos sold 49,982 shares of Amneal Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
49,982
Price
$0.00
Total value
N/A
InsiderKonidaris Tasos
Role—
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after87,963
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.; On March 4, 2024, the reporting person was granted 175,926 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.